Earlier this month our team attended the thirty-fifth annual International Conference on…
My beloved company Insilico Medicine, Inc. today announced a research collaboration with computationally-driven biopharmaceutical company A2A Pharmaceuticals to develop novel small molecules for Duchenne…
Today, we are happy to announce the publication of our new research paper titled “Reinforced Adversarial Neural Computer for De Novo Molecular Design” in The Journal of Chemical Information and Modeling. It is one of the coolest…
